2860 Stories, most recent news story added 41 minutes ago
Some women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had stopped responding to other medicines, doctors reported Friday.
Women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had stopped responding to other treatments, doctors reported Friday.
FRIDAY, Dec. 11 (HealthDay News) -- New therapies and new spins on existing treatments are offering hope for patients with breast cancer, especially those with metastatic disease, according to research being presented this week at the annual San Antonio Breast Cancer Symposium in San Antonio, Texas.
Breast cancer survivors who have just a few alcoholic drinks per week are more likely than women who drink little or no alcohol to see their breast cancer return, according to research presented today at an annual meeting of breast cancer specialists.
Chemotherapy helps improve breast cancer survival in post-menopausal women, adding to a long-standing debate about how best to treat these women, U.S. researchers said Thursday.
ODENSE, Denmark, Dec. 11 (UPI) -- Obesity is linked with poorer breast cancer outcomes, Danish researchers found.
Dec. 11 (Bloomberg) -- Onyx Pharmaceuticals Inc. and Bayer AG said their Nexavar pill, approved for liver and kidney tumors, extended the lives of women with advanced breast cancer by delaying growth of malignancies that had spread or recurred.
TORONTO, Dec. 11 (UPI) -- Canadian researchers advise women at high risk of breast cancer to get mammograms and a magnetic resonance imaging to detect cancers earlier.
OAKLAND, Calif., Dec. 11 (UPI) -- Women who have at least three to four alcoholic drinks per week have a 1.3-fold greater chance of breast cancer recurrence, U.S. researchers found.
A landmark lawsuit is challenging the patents Myriad Genetics holds on the so-called breast cancer genes — patents that make Myriad the sole provider of a crucial genetic test. Do patents on genes spur research and innovation, or harm patients? Two experts share their views.
Two new studies suggest that bisphosphonate drugs taken to prevent bone loss may help fight breast cancer.
Open slideshowReuters
Open slideshowReuters
Open slideshowAFP/Keystone/File
Open slideshowAFP/Keystone/File
